EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of Gut Dysbiosis with Disease Phenotype and Treatment in Systemic Lupus Erythematosus

Irene Medina-Martínez iD, Rocío Gil-Gutiérrez iD, Jorge García-García, Francisco Javier de la Hera-Fernández iD, Nuria Navarrete-Navarrete, Mónica Zamora-Pasadas iD, Norberto Ortego-Centeno, José Luis Callejas-Rubio, Federico García-García iD, Julio Gálvez-Peralta iD, Alba Rodríguez-Nogales iD, María Correa-Rodríguez iD und 1 weitere

Medical Sciences · 2025

DOI: 10.3390/medsci13030151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, 2025. Verfasst von Irene Medina-Martínez und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Granada, 18016 Granada, Spain. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Dysbiosis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: B-CTS-100-UGR20, Consejería de Economía, Innovación y Ciencia de la Junta de Andalucía I+D+i Programa operativo FEDER Andalucía 2014-2020, B-CTS-100-UGR20, I+D+i Programa operative FEDER Andalucía 2014–2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gut dysbiosis has been associated with the development of autoimmune diseases, including systemic lupus erythematosus (SLE). Although previous studies suggest microbial alterations in SLE, evidence at the species level and its clinical relevance remain limited. This study aimed to characterise the gut microbiota at species level in SLE patients and evaluate its association with clinical features. Materials and methods: A total of 57 SLE patients and 57 matched controls were included. Faecal samples were collected using the OMNIgene-GUT kit, and microbial DNA was extracted with the Maxwell RSC PureFood GMO kit. Metagenomic sequencing was performed using the Illumina MiSeq platform, and the data was analysed with QIIME2. Microbial diversity and relative abundance were assessed using the phyloseq package, and differentially abundant taxa were identified using DESeq2. Clinical subgroups among SLE patients were identified via k-means clustering.

Results

SLE patients exhibited significantly different beta diversity compared to controls (p = 0.001), with increased abundance of Pseudomonadota (3.81% vs. 6.80%, p < 0.05) and decreased Bacteroidota (53.42% vs. 38.04%, p < 0.05). Only 10 bacterial species were consistently present across all SLE samples, including Akkermansia muciniphila, Bacteroides dorei, and Lactobacillus gasseri. Hypertensive patients and those treated with corticosteroids presented a marked depletion of key microbial taxa. Conversely, Belimumab-treated patients displayed a distinct microbiota enriched in species such as Alistipes shahii and Prevotella corporis.

Conclusions

This study confirms significant gut microbiota alterations in SLE and pinpoints microbial profiles associated with clinical subgroups. These findings suggest gut dysbiosis may contribute to SLE pathogenesis and indicate biomarkers for disease stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicDysbiosisGastrointestinal MicrobiomeHumansFemaleMaleAdultMiddle AgedPhenotypeFecesCase-Control Studies

Stichwörter der Autor:innen

autoimmune diseasesdrug therapydysbiosisgastrointestinal microbiomehypertensionmetagenomic sequencingsystemic lupus erythematosus

Autor:innen und Institutionen

  • University of Granada, 18016 Granada, Spain.
  • Department of Nursing, Faculty of Health Sciences, University of Granada, 18071 Granada, Spain.
  • Institute for Biosanitary Research of Granada (ibs.Granada), 18012 Granada, Spain.
  • Microbiology Service, San Cecilio University Hospital, 18016 Granada, Spain.
  • Systemic Autoimmune Diseases Unit, San Cecilio University Hospital, 18016 Granada, Spain.
  • Systemic Autoimmune Diseases Unit, Virgen de las Nieves University Hospital, 18014 Granada, Spain.

ORCID-Profile: Irene Medina-Martínez, Rocío Gil-Gutiérrez, Francisco Javier de la Hera-Fernández, Mónica Zamora-Pasadas, Federico García-García, Julio Gálvez-Peralta, Alba Rodríguez-Nogales, María Correa-Rodríguez

Förderung

  • B-CTS-100-UGR20, Consejería de Economía, Innovación y Ciencia de la Junta de Andalucía I+D+i Programa operativo FEDER Andalucía 2014-2020
  • B-CTS-100-UGR20, I+D+i Programa operative FEDER Andalucía 2014–2020

Zitieren

APA

Medina-Martínez, I., Gil-Gutiérrez, R., García-García, J., de la Hera-Fernández, F. J., Navarrete-Navarrete, N., Zamora-Pasadas, M., Ortego-Centeno, N., Callejas-Rubio, J. L., García-García, F., Gálvez-Peralta, J., Rodríguez-Nogales, A., Correa-Rodríguez, M., & Rueda-Medina, B. (2025). Association of Gut Dysbiosis with Disease Phenotype and Treatment in Systemic Lupus Erythematosus. Medical Sciences. https://doi.org/10.3390/medsci13030151

Vancouver

Medina-Martínez I, Gil-Gutiérrez R, García-García J, de la Hera-Fernández FJ, Navarrete-Navarrete N, Zamora-Pasadas M, et al. Association of Gut Dysbiosis with Disease Phenotype and Treatment in Systemic Lupus Erythematosus. Medical Sciences. 2025. doi:10.3390/medsci13030151

BibTeX
@article{MedinaMartnez2025,
  author = {Medina-Martínez, Irene and Gil-Gutiérrez, Rocío and García-García, Jorge and de la Hera-Fernández, Francisco Javier and Navarrete-Navarrete, Nuria and Zamora-Pasadas, Mónica and Ortego-Centeno, Norberto and Callejas-Rubio, José Luis and García-García, Federico and Gálvez-Peralta, Julio and Rodríguez-Nogales, Alba and Correa-Rodríguez, María and Rueda-Medina, Blanca},
  title = {Association of Gut Dysbiosis with Disease Phenotype and Treatment in Systemic Lupus Erythematosus},
  journal = {Medical Sciences},
  year = {2025},
  doi = {10.3390/medsci13030151}
}
Kostenlos starten →